Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.50 |
| ▸ | HSD11B1 | P28845 | 6/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | GRM5 | P41594 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | USP2 | O75604 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.47 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16852620 | 0.98 | CYP3A4 (0.53) | CYP3A4CYP2C19HIF1ACYP2D6HSD11B1 | |
| SCHEMBL12335229 | 0.92 | GRM5 (0.58) | CYP3A4CYP2C19HIF1ACYP2D6HSD17B10 | |
| SCHEMBL5986519 | 0.89 | OPRM1 (0.54) | CYP3A4CYP2C19HIF1ACYP2D6HSD17B10 | |
| SCHEMBL10466780 | 0.87 | USP2 (0.53) | CYP3A4CYP2C19HIF1ACYP2D6HSD17B10 | |
| SCHEMBL18711489 | 0.85 | CYP3A4 (0.55) | CYP3A4CYP2C19HIF1ACYP2D6HSD17B10 | |
| SCHEMBL18711490 | 0.85 | USP2 (0.55) | CYP3A4CYP2C19HIF1ACYP2D6HSD17B10 | |
| SCHEMBL24279550 | 0.85 | CYP3A4 (0.46) | CYP3A4CYP2C19HIF1ACYP2D6HSD11B1 | |
| SCHEMBL23763347 | 0.83 | CYP1A2 (0.52) | CYP3A4CYP2C19HIF1ACYP2D6HSD17B10 | |
| SCHEMBL21078057 | 0.82 | CYP3A4 (0.47) | CYP3A4CYP2C19HIF1ACYP2D6HSD17B10 | |
| SCHEMBL4066199 | 0.81 | HSD11B1 (0.54) | CYP3A4CYP2C19HIF1AHSD11B1GRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1485352-B1 | AZASPIRO COMPOUNDS FOR THE TREATMENT OF PAIN | SANOL ARZNEI SCHWARZ GMBH (DE) | 2005-06-29 | — | — | EP | claimed |
| EP-1520854-A2 | Aza-Spirocompounds for the treatment of pain | SCHWARZ PHARMA AG (DE) | 2005-04-06 | — | — | EP | claimed |
| EP-3842431-A1 | [1,2,4]TRIAZOLO[1,5-A]PYRIDINE COMPOUND AS JAK INHIBITOR AND APPLICATION THEREOF | Zhuhai United Laboratories Co., Ltd (CN) | 2021-06-30 | — | — | EP | disclosed |
| US-20050288351-A1 | Azaspiro compounds for the treatment of pain | SCHWARZ PHARMA AG (DE) | 2005-12-29 | — | — | US | disclosed |
| EP-1485352-B1 | AZASPIRO COMPOUNDS FOR THE TREATMENT OF PAIN | SANOL ARZNEI SCHWARZ GMBH (DE) | 2005-06-29 | — | — | EP | disclosed |
| EP-1520854-A2 | Aza-Spirocompounds for the treatment of pain | SCHWARZ PHARMA AG (DE) | 2005-04-06 | — | — | EP | disclosed |
| EP-1485352-A1 | AZASPIRO COMPOUNDS FOR THE TREATMENT OF PAIN | SCHWARZ PHARMA AG (DE) | 2004-12-15 | — | — | EP | disclosed |
| WO-2003074486-A1 | AZASPIRO COMPOUNDS FOR THE TREATMENT OF PAIN | SCHWARZ PHARMA AG (DE) | 2003-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288351-A1 | Azaspiro compounds for the treatment of pain | TPMT, P2RY13, OPRL1 | CYP3A4 1954/4885CYP2C19 2524/4885HIF1A 810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.